Sign up to gain complete access to Medznat
Please verify that you are a Healthcare Professional. Register for complete access to all the content!
First gene therapy for metastatic synovial sarcoma earns FDA's OK...
Afamitresgene autoleucel intravenous infusion represents a pivotal advance in treating metastatic malignant synovioma, which is crucial for patie...
Takeda and Dr. Reddy’s join forces to launch Vonoprazan in India
Dr. Reddy’s has partnered with Takeda to launch Vonoprazan (VONO™), a novel acid blocker enhancing its GI treatment offerings in Indi...
FDA clears path for Aflibercept Biosimilars in macular degenerati...
Aflibercept Biosimilars intravitreal solutions are now FDA-approved as interchangeable biosimilars.
FDA gives green light to Pivmecillinam for UTI
Pivmecillinam, an extended-spectrum penicillin antibiotic has been approved for women aged 18 and older with uncomplicated urinary tract infectio...
Another high-concentration Adalimumab Biosimilar approved by the...
High-concentration, citrate-free type of adalimumab-adbm that halves injection volume is now approved for chronic inflammatory dis...
FDA approves antibiotic with triple treatment potential!
Ceftobiprole medocaril sodium injection is effective for 3 acute bacterial infections.
FDA approves the ‘first-ever’ oral therapy for eosinophilic esoph...
Budesonide oral suspension presents as a reliable FDA-approved therapy for the relief of eosinophilic esophagitis, backed by robust clinical data...
Tirzepatide injection gets FDA approval for chronic weight contro...
FDA has granted approval for Tirzepatide injection to mitigate chronic weight issues in adults battling obesity or overweight, along with at leas...
FDA releases alert regarding invasive disease risk in preterm inf...
As per the FDA, the administration of probiotics formulated to contain live bacteria or yeast to preterm infants in hospital settings poses a sig...
WHO recommends multivitamins for pregnancy in updated essential m...
WHO has updated its Essential Medicines List to include a range of essential multivitamins and micronutrient supplements for pregnant women, aimi...
FDA greenlights first biosimilar for multiple sclerosis treatment
For the management of multiple sclerosis, the FDA has granted approval to the first biosimilar (Natalizumab-sztn).
WHO recommends Rituximab off-label use in multiple sclerosis
WHO has endorsed groundbreaking public health measures concerning novel Essential Medicines for the treatment of multiple sclerosis.
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.
